http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AP-9400618-A0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-757
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-1804
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-757
filingDate 1994-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ef301ef6cab3e62a5eb5309972f269a
publicationDate 1995-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AP-9400618-A0
titleOfInvention Benzylimidazopyridine derivative as angiotensin 11 receptor antagonist.
abstract 1-[4'-(2"-Ethyl-5",7"-dimethylimidazo[4,5-b]pyridin-3-yl)methylphenyl]cyclopent-3-ene-1-carboxylic acid and its pharmaceutically acceptable salts inhibit angiotensin ll in mammals and useful in treating conditions such as hypertension, congestive heart failure and glaucoma and as the active ingredient in pharmaceutical compositions for treating such conditions.
priorityDate 1993-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9929527
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410472002
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12238407
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426413123

Total number of triples: 21.